GH1 and Hyperglycemia: As discussed previously, the experimental loss of the hepatic GHR/JAK2/STAT5 signal cascade dramatically reduces circulating IGF1 levels, leading to a rise in circulating GH levels and thereby reducing systemic insulin sensitivity, leading to hyperinsulinemia, hyperglycemia, and WAT lipolysis.